G. Tarasova

Determining the optimal duration of treatment for antineutrophil cytoplasmic antibodyassociated systemic vasculitides. When can therapy be discontinued?

Antineutrophil cytoplasmic antibody-associated systemic vasculitides (AAV) are a group of severe, potentially fatal autoimmune diseases that include granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis. The introduction of a modern therapeutic strategy based on t...